Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 166.27M P/E - EPS this Y 15.80% Ern Qtrly Grth -
Income -138.49M Forward P/E -1.42 EPS next Y 5.00% 50D Avg Chg -11.00%
Sales 16.34M PEG - EPS past 5Y - 200D Avg Chg -29.00%
Dividend N/A Price/Book 1.17 EPS next 5Y - 52W High Chg -68.00%
Recommedations 1.90 Quick Ratio 2.91 Shares Outstanding 106.40M 52W Low Chg 14.00%
Insider Own 2.30% ROA -41.70% Shares Float 90.55M Beta 0.43
Inst Own 40.33% ROE -124.41% Shares Shorted/Prior 12.80M/8.82M Price 1.87
Gross Margin - Profit Margin - Avg. Volume 882,153 Target Price 5.17
Oper. Margin -293.47% Earnings Date May 9 Volume 587,289 Change -1.58%
About Gritstone bio, Inc.

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious diseases. Its primary product candidate is GRANITE, an individualized immunotherapy candidate, which is in Phase 2/3 clinical trials for the treatment of microsatellite stable colorectal cancers; and has completed Phase 1/2 clinical trials for treating solid tumors. The company is also developing SLATE, an off-the-shelf immunotherapy candidate, which is in Phase 2 clinical trials for the treatment of metastatic solid tumors. In addition, it develops CORAL, a COVID-19 vaccine program; and a therapeutic vaccine candidate that is in Phase 1 clinical trials designed to treat and cure human immunodeficiency virus (HIV) infection. Gritstone bio, Inc. has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

Gritstone bio, Inc. News
06:00 AM Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024
04/29/24 Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors
04/15/24 Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)
04/08/24 Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
04/08/24 Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024
04/01/24 Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering
04/01/24 Gritstone bio Announces Proposed Public Offering
04/01/24 Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
03/19/24 3 Speculative Stocks You Can Buy for $3 or Less
03/08/24 Gritstone bio, Inc. (NASDAQ:GRTS) Just Reported And Analysts Have Been Cutting Their Estimates
03/07/24 Gritstone bio Full Year 2023 Earnings: Beats Expectations
03/05/24 Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
02/29/24 Gritstone bio Announces Workforce Reduction
02/12/24 Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical Trial
02/08/24 Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/31/24 3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge Potential
01/23/24 Gritstone bio (NASDAQ:GRTS) investors are sitting on a loss of 87% if they invested three years ago
01/17/24 Gritstone bio to Participate in Upcoming Investor Conference
12/13/23 Forecast: Analysts Think Gritstone bio, Inc.'s (NASDAQ:GRTS) Business Prospects Have Improved Drastically
11/20/23 Gritstone bio to Participate in Upcoming Investor Conferences
GRTS Chatroom

User Image Olininvestr Posted - 5 hours ago

$GRTS 😂 the problem with turning off comments on LinkedIn is that you have to keep them off or appear selective … If only they were off because they don’t want to have a slippage of info.. Curious what is the best strategy…Would you engage or keep them off?

User Image Olininvestr Posted - 5 hours ago

$GRTS any ideas of CEPI would award grts for something additional? Also good for HIV / Gilead

User Image Stock_Titan Posted - 5 hours ago

$GRTS Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024 https://www.stocktitan.net/news/GRTS/gritstone-bio-highlights-the-durability-and-potential-broad-utility-a4m5lh850gib.html

User Image aferslid Posted - 6 hours ago

$GRTS Nice way to speak to his shareholders. Winds are changing direction 🔥

User Image Scooter0732 Posted - 11 hours ago

$GRTS What is the appeal of this company? Like how do people look at it and see an opportunity and not the sinking black hole of eternal filth that it is? Asking for a friend…

User Image Konasurf Posted - 22 hours ago

$GRTS what is GRTS doing to stay compliant. Seen nothing about a reverse split or plan. What is the company doing to dramatically reduce costs. C suit is big and expensive for a penny stock. Need a coo and cfo? Is an svp of BD and HR required. Why add a new board member? Does current board and CEO not have capacity or capability to get investors? It does not seem like there is any sense of urgency to avoid BK, delisting or further dilution. The market and investors have obviously lost trust in the company. What is GRTS doing to regain trust. CEO doing roadshows and staying in fancy hotels and expensive flights have done nothing to instill confidence. Need to do something different and quickly.

User Image Biohacker Posted - 23 hours ago

$GRTS bios ripping today ,GRTS in a coma . This new hire definitely big news . How many stock options will he get ? Will liquidate remainder of my assets and load up more cheap shares .Those crooked market makers holding it down so they can load up more .Blackrock ,Citadel,and Bridgewater all in on it . Big pharma will start bidding war soon . Granite hands and Slate balls till victory.

User Image illdefinedmind Posted - 1 day ago

$GRTS Trust me you are overthinking this being about Roche. Look at the actual connections with the Gritstone board AA to Webster- Both were on the TCR2 board prior to TCR2 merging with Adaptimmune (Webber was the Chair) Elaine V. Jones to Webster - Both are on the NextCure board Shefali Agarwal to Webster - Agarwal is a Scientific Advisor for Imvax where Webster is on the board Do you now think this is about Roche or maybe there's something else going on. Purely assumption but my guess is there's a power struggle going on between AA/The board and a major shareholder. and bringing Webster in helps solidify that vote since he's got relationships with a lot of the board. This effectively puts a 4-3 vote in AA/Jones' side after Krognes leaves. Steve Krognes meanwhile had been our longest serving board member coming in pre-IPO so he's served his purpose of getting things to where they are now. @jfz119 @XxGodFatherxX @LTTrader

User Image nguyen36858 Posted - 1 day ago

$GRTS could grts benefit from this if this happens?

User Image Plungeprotectiongang Posted - 1 day ago

$COCP $EPIX don’t forget Kevin is also massively long $GRTS

User Image reveultoL Posted - 1 day ago

$GRTS addition of Webster to their team suddenly makes my quadruple equation to an n-tuple, now what that ‘n’ is, let’s wait and find out..it’s not a long wait here on

User Image Peterpaypaul Posted - 1 day ago

$GRTS You ain't bringing Stephen Webster in to sell hotdogs. This appears to be positioning for a takeover and shopping deals in the near future....,🤔

User Image G101SPM Posted - 1 day ago

$GRTS $0.825 bid. DAC $1.19. EXIT $3.00. RETAIN POSITION UPDATE: announced the appointment of Stephen Webster to its Board of Directors. A veteran finance executive in the biotechnology industry, Mr. Webster has served as an executive for several renowned companies and held key roles in raising capital, business development transactions and operations for over 30 years.. “We are excited to welcome Stephen Webster to our Board of Directors at this important and exciting time for Gritstone. His distinguished track record and business development expertise will be invaluable as we prepare for mature Phase 2 GRANITE data and a period of potential significant growth,” said Andrew Allen, M.D., Ph.D., Co-founder, President, and Chief Executive Officer of Gritstone. “Stephen’s highly informed, educated and engaged approach will be a great asset as we continue to execute on our strategic initiatives and drive long-term value for our shareholders.”

User Image LTtrader04 Posted - 1 day ago

$GRTS the guy is the master in orchestrating acquisitions.

User Image 011gwerc01 Posted - 1 day ago

$GRTS sounds promising

User Image StockPug Posted - 1 day ago

$GRTS Mr. Webster served as the Chief Financial Officer of Spark Therapeutics, a publicly traded gene therapy biotechnology company, from July 2014 until its acquisition by Roche for $4.3 billion in December 2019. He was previously Senior Vice President (SVP) and Chief Financial Officer of Optimer Pharmaceuticals, a publicly traded biotechnology company, from July 2012 until its acquisition by Cubist Pharmaceuticals in October 2013. Prior to joining Optimer, Mr. Webster served as SVP and Chief Financial Officer of Adolor Corporation, a biopharmaceutical company, from 2008 until its acquisition by Cubist Pharmaceuticals in 2011. 👀

User Image Noobs_inc Posted - 1 day ago

$GRTS this guy screams buyout

User Image aferslid Posted - 1 day ago

$GRTS excellent PR, very great move. 🔥

User Image Bobby_XiDada Posted - 1 day ago

$GRTS https://ir.gritstonebio.com/news-releases/news-release-details/gritstone-bio-announces-appointment-stephen-webster-its-board finally someone with finance experience

User Image King316 Posted - 2 days ago

$GRTS so to be realisitc. When do they need another cash raise? Please no shittalking...

User Image KimJungooner Posted - 3 days ago

$GRTS ALL OF YOU ARE DEADBEAT GAMBLING ADDICTS AND YOU WILL LOSE EVERYTHING I THINK I SAW ANDREW ALLEN AT THE CASINO LOSING HIS SHIRT AT THR SLOT MACHINES HE IS A BUM PT BANKRUPTCY

User Image arthura Posted - 3 days ago

$GRTS Have a good weekend all! She seems to have her bottom, albeit too low…Slap that ass if so inclined, she likes it!

User Image Tehran_Times Posted - 3 days ago

$GRTS go up baby go up. Need this cash for a good cause

User Image novumcarpediem Posted - 3 days ago

$GRTS Gorilla adenovirus-based cancer vaccine, better than chimpanzee ? LOL

User Image Keekster1 Posted - 3 days ago

$GRTS CDC describes first known cases of HIV transmitted via cosmetic injections https://www.yahoo.com/news/cdc-describes-first-known-cases-214804916.html

User Image StardustTrader Posted - 3 days ago

$GRTS volume is behind us. Now have to wait for positive catalyst

User Image Peterpaypaul Posted - 3 days ago

$GRTS A lot of people/ Retail Investors are oblivious to this space. I am talking about Immuno-Oncology and saMRNA. Taking full advantage of this opportunity is a great strategy especially when the stock GRTS and Biotech as a whole is in the doldrums. Perhaps the news cycle is starting to ignite and release ground breaking news shortly. I am excited about this...., WHY ????? I like to be early....... 😊😁😊

User Image CatalystInvestments Posted - 3 days ago

$GRTS https://www.nature.com/articles/d41586-024-00841-y?utm_medium=Social&utm_campaign=nature&utm_source=Twitter#Echobox=1714120550

User Image Peterpaypaul Posted - 3 days ago

$GRTS It's coming, that news cycle,

User Image Peterpaypaul Posted - 3 days ago

$GRTS a little something, to nibble on

Analyst Ratings
JMP Securities Market Outperform Apr 2, 24
HC Wainwright & Co. Buy Mar 6, 24
JMP Securities Market Outperform Feb 28, 24
Piper Sandler Overweight Sep 28, 23
HC Wainwright & Co. Buy Aug 10, 23
HC Wainwright & Co. Buy May 15, 23
B. Riley Securities Buy Mar 28, 23
HC Wainwright & Co. Buy Mar 14, 23
HC Wainwright & Co. Buy Feb 15, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Economides Vassiliki See Remarks See Remarks May 23 Buy 1.9024 12,000 22,829 214,058 05/24/23